NCT07130643 2025-08-19Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast CancerHubei Cancer HospitalPhase 2 Active not recruiting40 enrolled
NCT05633914 2023-02-21Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast CancerHunan Cancer HospitalPhase 2 Unknown90 enrolled